Key Takeaways
- Strong H1 profit growth: Standalone H1 PAT grew 25% YoY to ₹1,053 crore, driven by higher urea volumes and a 38% jump in CPC segment contribution.
- CPC is the growth engine: The crop protection chemicals business outperformed the industry on the back of a 62-product portfolio, strong alliances, and a cash-heavy sales model, even as unseasonal rains created a soft QoQ quarter.
- Complex fertiliser swings are noise, not signal: Revenue collapsed QoQ due to availability constraints, while a temporary subsidy over-receipt inflated trade payables; both are expected to normalize within months.
- The TAN project is the next big capex cycle: A firm October 2025 completion date and ~₹600 crore cumulative spend by FY25-end signal a material step-up in capital work in progress in coming quarters.
- What to watch next quarter: The sell-through of carried-forward complex fertiliser stock, normalization of the elevated trade payables, and any concrete timeline for the next energy efficiency implementation.
Crop Protection Chemicals: The Standout Performer
- Volume and margin-led growth: Q2 segment revenue rose 18% YoY to ₹289 crore and contribution grew 36% YoY to ₹83 crore; H1 contribution grew 38% YoY to ₹164 crore, outpacing revenue growth and signalling margin expansion.
- Outperformance rooted in portfolio breadth: The company fields 62 products across weedicides, fungicides and insecticides, giving farmers a range of options rather than dependence on one or two verticals. Strong planning, sourcing and validation processes match farmer requirements, while alliances with Gen 1X patented combination products add differentiation.
- Cash model aids liquidation: 60% to 65% of CPC sales happen on cash, providing instant liquidation and reducing channel inventory risk.
- QoQ dip is seasonal, not structural: Revenue fell from ₹342 crore in Q1 to ₹289 crore in Q2 because late and unseasonal rains affected absorption in some territories; management advises judging the business on a half-yearly basis (H1: ₹540 crore to ₹632 crore, 17% growth).
- No product returns despite erratic monsoon: Unlike some peers, the company did not face returns because it assesses the market accurately and does not pump up the channel just to hit numbers.
Baijal: "We have a very strong and solid planning process, a sourcing process, a validation process for the value for money. And I think that's the reason why we have a range of options for the farmers instead of being stuck in one or two verticals."
Urea: Steady Volume-Led Profit Growth
- Optimal capacity utilization: All urea manufacturing units ran at optimal capacity, with production rising to 9.34 lakh MT from 9.08 lakh MT YoY. Sales increased to 9.65 lakh MT from 8.38 lakh MT YoY, with roughly 1 lakh additional tons sold contributing directly to profit growth.
- Subsidy receivables normalized sharply: Subsidy outstanding reduced dramatically, covering both billed and unbilled amounts; the government has a substantial budget and pays on time when bills are raised efficiently.
- Energy efficiency roadmap extends to 2028: Multiple projects are under consideration, with some awarded to consultants for engineering work; at least 3-4 in-house plans have been generated and vetted by engineering consultants. When pressed, management quantified the next 3% efficiency improvement as contributing an additional ₹35-40 crore to EBITDA.
- Gadepan II turnaround scheduled: The plant will be taken for a planned turnaround in March 2025.
Complex Fertiliser & Balance Sheet Noise
- Revenue collapse is an availability story: Complex fertiliser revenue dropped to ₹261 crore in Q2 from ₹1,111 crore in Q1 and ₹1,972 crore in the prior-year September quarter, driven entirely by availability constraints that restricted sales. Carried-forward stock will be sold in the current and next quarter.
- Trade payables spike is temporary: Trade payables shot up to ₹2,012 crore and other financial liabilities to ₹690 crore, primarily because the company received slightly more subsidy than it was eligible for under the escalation/de-escalation process. This is expected to normalize over the next 1-3 months as the excess is paid back.
- Investments mirror the payable: Investments rose to ₹2,783 crore because money owed to the government has been converted into cash and placed in mutual fund investments, generating interest income that flows through other income.
Baijal: "Fortunately or unfortunately, we were receiving a little bit more subsidy from the government than was eligible, to that extent this is payable. Over a period of time, maybe in the next month, two months, three months, we will be paying that off."
TAN Project & IMACID: The Next Growth Pillars
- TAN project on track for October 2025: The EPC contract has been awarded to Larsen & Toubro; major payments will occur when equipment arrives, at which point capital work in progress will increase suddenly. Cumulative spend is expected to reach approximately ₹600 crore by the end of FY25.
- IMACID delivering higher production and margins: The Morocco joint venture is producing roughly 40,000 tons per month with better margins; management sees no negatives in terms of repeating this performance.
- IMACID board approves capacity expansion: A 2,00,000-ton Phosphoric Acid capacity expansion has been approved; engineering work has been awarded and the project will take approximately 2.5 to 3 years to complete, subject to achieving the zero date. No financing constraints exist.
New Product Pipeline: Biologicals, Seeds & Specialty Nutrition
- Biologicals push gaining shape: The company intends to be broad-spectrum in biologicals, spanning Actives, Stimulants and Crop Protection Chemicals; alliances are being worked upon, including sponsoring research activities. A biological nematicide will be introduced shortly after successful internal field tests.
- Nano bio-phosphorus launched: 'Uttam Pranaam' has been added to the specialty nutrients portfolio; it is derived from a biological process rather than chemical, and approximately 2 lakh bottles had been sold through September 2024.
- Seeds entry to complete the agri-input profile: The company will enter hybrid and research variety seeds as a new focus area in coming quarters, with sales and marketing expected to begin from Kharif 2025 onwards.
- Water-soluble fertilisers positioned for precision farming: Currently low penetration but expected to grow faster with the expansion of polyhouses, drip irrigation, and crop diversification into fruits and vegetables.
- Seed-to-harvest program scaling: Over 3,800 farmer meetings, 3,000-plus demos, and 4 soil sample days collecting over 2,000 samples were conducted; a total of 58,000 soils have been tested for macro and micro-nutrients.
Channel Discipline & The Return-Free Quarter
- Supply chain process prevents channel stuffing: The company does not pump up the channel just to achieve numbers; the range of products creates flexibility that, combined with accurate market assessment, avoided the product returns some peers faced from the inconsistent monsoon.
Baijal: "We do not pump-up the channel just because we want to achieve these numbers. And as I said, the range of products that we have creates that flexibility with us."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| TAN project completion | EPC with L&T; major payments on equipment arrival | October 2025 |
| TAN project cumulative spend | ~₹600 crore | By end of FY25 |
| Energy efficiency EBITDA contribution | ₹35-40 crore additional EBITDA from next 3% efficiency improvement | No date (roadmap to 2028) |
| Trade payables normalization | Excess subsidy received to be paid back | Next 1-3 months |
| Complex fertiliser stock sell-through | Carried-forward stock to be sold | Current quarter and next quarter |
| IMACID Phosphoric Acid expansion | 2,00,000-ton capacity addition; engineering awarded | 2.5 to 3 years from zero date |
| Seeds business launch | Sales and marketing of hybrid and research variety seeds | Kharif 2025 onwards |
| Gadepan II turnaround | Planned plant turnaround | March 2025 |
Key Metrics
| Metric | Q2 FY25 |
|---|---|
| Standalone revenue | Not explicitly stated for Q2; complex fertiliser revenue ₹261 cr, down from ₹1,111 cr QoQ and ₹1,972 cr YoY |
| Standalone EBITDA | ₹834 cr, growth of ~20% YoY vs ₹697 cr |
| Standalone PAT | ₹500 cr, growth of 34% YoY vs ₹372 cr |
| Consolidated PAT | ₹536 cr, growth of 41% YoY vs ₹381 cr |
| H1 FY25 standalone EBITDA | ₹1,776 cr, growth of ~20% YoY vs ₹1,475 cr |
| H1 FY25 standalone PAT | ₹1,053 cr, growth of 25% YoY vs ₹842 cr |
| H1 FY25 consolidated PAT | ₹985 cr, growth of 37% YoY vs ₹720 cr |
| Urea production | 9.34 lakh MT, up from 9.08 lakh MT YoY |
| Urea sales | 9.65 lakh MT, up from 8.38 lakh MT YoY |
| Subsidy received in Q2 | ₹4,713 cr |
| CPC & SN segment revenue | ₹289 cr, growth of 18% YoY vs ₹245 cr |
| CPC & SN segment contribution | ₹83 cr, growth of 36% YoY vs ₹61 cr |
| CPC product portfolio | 62 products of distinct chemistries |
| Nano bio-phosphorus 'Uttam Pranaam' bottles sold | ~2 lakh bottles cumulative till Sep 2024; 1.2 lakh bottles in Q2 |
| TAN project spend till Sep 2024 | ~₹388 cr, overall progress ~37% |
| TAN project Board-approved cost | ~₹1,600 cr, completion expected by October 2025 |
| Energy efficiency EBITDA contribution | ~₹35 cr to ₹40 cr |
| Gas price for the quarter | $16.7 to $17 per MMBTU |
| Gadepan I & II production | 5.71 lakh MT, up from 5.51 lakh MT YoY |
| Gadepan III production | 3.62 lakh MT, up from 3.57 lakh MT YoY |
| IMACID production capacity | ~40,000 tons per month |
| Trade payables (creditors other than MSME) | ₹2,012 cr |
| Other financial liabilities | ₹690 cr, up from ₹406 cr and ₹761 cr in prior periods |
| Investments | ₹2,783 cr |
| Complex fertiliser segment liabilities | ₹772 cr, up from ₹567 cr QoQ |
| Cumulative expected TAN spend by end of FY25 | ~₹600 cr |